2019年11月4日（月）
That second flight is likely be delayed beyond 2021
The first test flight of NASA&Vacuum Storage Bag Factory
039;s Orion capsule, designed to one day carry people to Mars, has been delayed until 2019 US Navy divers and other personnel practicing for recovery of Orion on its return from deep space missions, using a test version of the crew module (Photo: AFP) The first test flight of NASA's Orion capsule, designed to one day carry people to Mars, has been delayed until 2019 at the earliest due to high costs, the US space agency said Friday.
And then it is going to cost more, and we have the budget that we have to be considerate of and make sure we spend the minimum amount for this stuff moving forward," he added"Itis really the complexity of what we are trying to go do and build these systems.Concerns about containing costs, improving the heat shield on the spacecraft, and adding life support systems to the spaceship all factored into the decision, he told reporters on a conference call.The decision to delay the Orion test flights was made in partnership with the White House, NASA officials said.The unmanned test flight had been scheduled for November 2018 but was pushed back after the White House asked for a feasibility study of the cost, safety and technical constraints."They have asked us to look at the plan we have got today and see if we can keep going on that plan," he answered."NASA is building the world's most powerful rocket known as the Space Launch System (SLS) -- to propel the spacecraft to the area around the Moon and eventually to Mars."Well, we want to try to do it during my first term or at worst during my second term so we will have to speed that up a little bit ok?" Trump said, eliciting laughter from the astronauts floating # in microgravity.Manned exploration of Mars is expected to exceed $33 billion by 2033."."They have not asked us to go to Mars by 2024.Lightfoot was asked by reporters Friday if the White House meant that.NASA also decided against a proposal to add astronauts to the first mission, known as EM-1.No formal date has been set for the 2019 mission, but that should be coming in the next few months, said acting NASA Administrator Robert Lightfoot.
That second flight is likely be delayed beyond 2021, too, said Bill Gerstenmaier, associate administrator of NASA's Human Explorations and Operations Mission Directorate.Instead, the space agency will stick to its original plan of putting crew on the second test mission, known as EM-2, planned for August 2021 at the earliest."Even though it was feasible, it just didn't seem warranted in this environment," he said.Speaking to astronauts at the International Space Station last month, US President Donald Trump seemed to urge NASA to hurry along its efforts to send people to Mars -- a mission currently planned for the 2030s
039;s Orion capsule, designed to one day carry people to Mars, has been delayed until 2019 US Navy divers and other personnel practicing for recovery of Orion on its return from deep space missions, using a test version of the crew module (Photo: AFP) The first test flight of NASA's Orion capsule, designed to one day carry people to Mars, has been delayed until 2019 at the earliest due to high costs, the US space agency said Friday.And then it is going to cost more, and we have the budget that we have to be considerate of and make sure we spend the minimum amount for this stuff moving forward," he added"Itis really the complexity of what we are trying to go do and build these systems.Concerns about containing costs, improving the heat shield on the spacecraft, and adding life support systems to the spaceship all factored into the decision, he told reporters on a conference call.The decision to delay the Orion test flights was made in partnership with the White House, NASA officials said.The unmanned test flight had been scheduled for November 2018 but was pushed back after the White House asked for a feasibility study of the cost, safety and technical constraints."They have asked us to look at the plan we have got today and see if we can keep going on that plan," he answered."NASA is building the world's most powerful rocket known as the Space Launch System (SLS) -- to propel the spacecraft to the area around the Moon and eventually to Mars."Well, we want to try to do it during my first term or at worst during my second term so we will have to speed that up a little bit ok?" Trump said, eliciting laughter from the astronauts floating # in microgravity.Manned exploration of Mars is expected to exceed $33 billion by 2033."."They have not asked us to go to Mars by 2024.Lightfoot was asked by reporters Friday if the White House meant that.NASA also decided against a proposal to add astronauts to the first mission, known as EM-1.No formal date has been set for the 2019 mission, but that should be coming in the next few months, said acting NASA Administrator Robert Lightfoot.
That second flight is likely be delayed beyond 2021, too, said Bill Gerstenmaier, associate administrator of NASA's Human Explorations and Operations Mission Directorate.Instead, the space agency will stick to its original plan of putting crew on the second test mission, known as EM-2, planned for August 2021 at the earliest."Even though it was feasible, it just didn't seem warranted in this environment," he said.Speaking to astronauts at the International Space Station last month, US President Donald Trump seemed to urge NASA to hurry along its efforts to send people to Mars -- a mission currently planned for the 2030s
2019年10月30日（水）
Bedaquiline is the first new TB drug to be approved
Bedaquiline is the only drug which can be used on multi-drug resistant cases where all other drugs have failed. While the drug is available at the six sites shortlisted by the government, experts are waiting for the “ drug powder” used to check the drug susceptibility before it is prescribed to a patient.P. The drug was launch by Union health minister J. According to WHO, there are around 9 million new cases of TB detected and close to 2 million people die from the disease each year. “Bedaquiline has to be preserved till the end. After it is introduced, the drug would help over 600 patients,” added the official. A ‘specific’ powder is needed to check the drug resistancy.
Two months after the Union health ministry launched a miracle drug for tuberculosis, Bedaquiline, with great pomp and show, the drug has not been put to use on a single patient. Till the drug technicians don’t get it, the drug cannot be given to anyone,” an official said on condition of anonymity. Approved by the US regulator, Bedaquiline is used for treatment of multi-drug resistant TB as part of a combination therapy in adults. Earlier, results from randomised trials on the efficacy of the Bedaquiline which was published in the Lancet showed “significant reduction” in the infection period.. It is estimated that annually around 3,30,000 Indians die due to TB and emergence of multidrug-resistant TB in recent years poses a much serious health threat throughout the world. In India, TB is rated as a major public health problem and the country accounts for one-fifth of the global TB cases.
The drug’s approval was also based on studies that showed it killed bacteria more quickly than a control group taking the standard regimen. Significantly, the drug also got a push from the World Health Organisation (WHO) recently after it advised on the inclusion of Bedaquiline on the combination therapy of MDR TB in accordance with its existing guidelines. One patient Travel Vacuum Bag Suppliers would need 200 tablets. In India, 12 extensively drug resistant TB cases were detected at Hinduja Hospital of Mumbai early few years back.“Bedaquiline cannot be given to patients until the DST — which is a drug susceptibility test — are done. The health ministry had shortlisted six centres in India, including Ahmedabad, Gujarat, Chennai, Delhi and Guwahati, where the drug is launched for its introduction on patients who are found to be resistant to two vital primary drugs in DOTS Plus regimen. Twenty two countries, including South Africa, bear 80 per cent of the burden of TB worldwide. Discovered by scientists at Janssen, the pharmaceuticals unit of Johnson & Johnson, the FDA approval for a new TB drug comes after more than 50 years.
Bedaquiline is the first new TB drug to be approved by the US FDA in over 50 years.As per government records, nearly two million Indians develop TB each year. Mumbai is emerging as the ground zero of multi drug resistant TB. Bedaquiline, the “miracle drug” for rising drug-resistant population in India can be used as part of the treatment for patients suffering from multi-drug resistance (MDR) and extensively drug resistant (XDR) strains of bacteria. While, the government had in March procured 600 courses of Bedaquiline, it is lying unused, thanks to the callous approach of the government which is yet to procure the drug powder for laboratory testing for drug susceptibility.Two months after the Union health ministry launched a miracle drug for tuberculosis, Bedaquiline, with great pomp and show, the drug has not been put to use on a single patient. Nadda ahead of World TB day on March 21
Two months after the Union health ministry launched a miracle drug for tuberculosis, Bedaquiline, with great pomp and show, the drug has not been put to use on a single patient. Till the drug technicians don’t get it, the drug cannot be given to anyone,” an official said on condition of anonymity. Approved by the US regulator, Bedaquiline is used for treatment of multi-drug resistant TB as part of a combination therapy in adults. Earlier, results from randomised trials on the efficacy of the Bedaquiline which was published in the Lancet showed “significant reduction” in the infection period.. It is estimated that annually around 3,30,000 Indians die due to TB and emergence of multidrug-resistant TB in recent years poses a much serious health threat throughout the world. In India, TB is rated as a major public health problem and the country accounts for one-fifth of the global TB cases.
The drug’s approval was also based on studies that showed it killed bacteria more quickly than a control group taking the standard regimen. Significantly, the drug also got a push from the World Health Organisation (WHO) recently after it advised on the inclusion of Bedaquiline on the combination therapy of MDR TB in accordance with its existing guidelines. One patient Travel Vacuum Bag Suppliers
would need 200 tablets. In India, 12 extensively drug resistant TB cases were detected at Hinduja Hospital of Mumbai early few years back.“Bedaquiline cannot be given to patients until the DST — which is a drug susceptibility test — are done. The health ministry had shortlisted six centres in India, including Ahmedabad, Gujarat, Chennai, Delhi and Guwahati, where the drug is launched for its introduction on patients who are found to be resistant to two vital primary drugs in DOTS Plus regimen. Twenty two countries, including South Africa, bear 80 per cent of the burden of TB worldwide. Discovered by scientists at Janssen, the pharmaceuticals unit of Johnson & Johnson, the FDA approval for a new TB drug comes after more than 50 years.Bedaquiline is the first new TB drug to be approved by the US FDA in over 50 years.As per government records, nearly two million Indians develop TB each year. Mumbai is emerging as the ground zero of multi drug resistant TB. Bedaquiline, the “miracle drug” for rising drug-resistant population in India can be used as part of the treatment for patients suffering from multi-drug resistance (MDR) and extensively drug resistant (XDR) strains of bacteria. While, the government had in March procured 600 courses of Bedaquiline, it is lying unused, thanks to the callous approach of the government which is yet to procure the drug powder for laboratory testing for drug susceptibility.Two months after the Union health ministry launched a miracle drug for tuberculosis, Bedaquiline, with great pomp and show, the drug has not been put to use on a single patient. Nadda ahead of World TB day on March 21
2019年10月25日（金）
According to global trade norms
The duty is aimed at ensuring fair trading practices and creating a level-playing field for domestic producers vis-a-vis foreign producers and exporters..In its probe, the directorate has to conclude whether the dumped products are impacting domestic industries. New Delhi: India has begun a probe into alleged dumping of aluminium and zinc coated flat products from China, Vietnam and Korea following a complaint from a domestic player.In a notification, DGTR said it has found "sufficient evidence" of dumping of the goods by these countries.The investigation would cover the period from October 2017 to September 2018. However, the directorate would also cover the data of 2015-18.According to global trade norms, a country is allowed to impose tariffs on such dumped products to provide a level- playing field to domestic manufacturers. The duty is imposed only after a thorough investigation by a quasi-judicial body, like DGTR in India.The product offers resistance to corrosion and is used in many applications and sectors including solar power projects, roofing, white goods and appliances, furniture and substrate for colour-coated steel.In a notification, DGTR said it has found "sufficient evidence" of dumping of the goods by these countries..Imposition of antidumping duty is Hanging vacuum bag permissible under the World Trade Organisation (WTO) regime..The company asked for an anti-dumping probe and imposition of duty on imports of flat-rolled product of steel, plated or coated with alloy of aluminum and zinc, from these countries.
According to global trade norms, a country is allowed to impose tariffs on such dumped products to provide a level- playing field to domestic manufacturers."The authority hereby initiates an investigation into the alleged dumping, and consequent injury to the domestic industry.The commerce ministry's arm Directorate General of Trade Remedies (DGTR) initiated the investigation on an application filed by JSW Steel Coated Products.to determine the existence, degree and effect of alleged dumping and to recommend the amount of antidumping duty, which if levied, would be adequate to remove the injury to the domestic industry," it said.In international trade parlance, dumping happens when a country or a firm exports an item at a price lower than the price of that product in its domestic market.Dumping impacts price of that product in the exporting country, hitting margins and profits of manufacturing firms.If established that dumping has caused material injury to domestic players, DGTR would recommend imposition of antidumping duty on the imports
permissible under the World Trade Organisation (WTO) regime..The company asked for an anti-dumping probe and imposition of duty on imports of flat-rolled product of steel, plated or coated with alloy of aluminum and zinc, from these countries.According to global trade norms, a country is allowed to impose tariffs on such dumped products to provide a level- playing field to domestic manufacturers."The authority hereby initiates an investigation into the alleged dumping, and consequent injury to the domestic industry.The commerce ministry's arm Directorate General of Trade Remedies (DGTR) initiated the investigation on an application filed by JSW Steel Coated Products.to determine the existence, degree and effect of alleged dumping and to recommend the amount of antidumping duty, which if levied, would be adequate to remove the injury to the domestic industry," it said.In international trade parlance, dumping happens when a country or a firm exports an item at a price lower than the price of that product in its domestic market.Dumping impacts price of that product in the exporting country, hitting margins and profits of manufacturing firms.If established that dumping has caused material injury to domestic players, DGTR would recommend imposition of antidumping duty on the imports
2019年10月22日（火）
The US is currently disputing retaliatory tariffs
The magnitude of the imbalance has continued into 2018, with Chinese imports totaling $205 billion in the first five months of the year and the deficit reaching $152 billion. “I’m ready to go to 500. Look, I’m not doing this for politics.” That is “taking away our big competitive edge.”D15.Earlier this month, the US imposed tariffs on $34 billion of Chinese imports.Trump is taking a more aggressive, protectionist posture on trade than his recent predecessors, sparking retaliatory measures from countries around the world and igniting disputes on multiple fronts.
US President Donald Trump Washington: President Donald Trump said he was ready to impose tariffs on all $500 billion of goods the US imports from China, remarks that sent financial markets retreating and threatened to escalate a trade clash with the Asian giant.”Along with pressing Chinese leaders to shrink the deficit, Trump’s administration has accused China of engaging in unfair trade practices by forcing American investors to turn over technologies to Chinese firms.”After criticizing the Fed in an interview, Trump again lambasted the central bank, saying “Tightening now hurts all that we have done.”Around $505 billion of Chinese goods came into the US in 2017, leading to a trade deficit of nearly $376 billion, US government data shows.Slams Federal Reserve’s decision to hike interest rates... In return, China levied taxes on the same value of US products.“We’re down a tremendous amount,” Trump said in an interview about trade imbalances with China on CNBC broadcast on Friday.US stock index futures, already down on trade worries, fell further after the interview. while the US is raising rates while the dollar gets stronger and stronger with each passing day.Meanwhile, Donald Trump on Friday attacked China and the EU for keeping their currencies artificially low to gain a trade advantage, while again blasting the Federal Reserve for raising interest rates.
The US is currently disputing retaliatory tariffs by China, the European Union, Canada, Mexico and Turkey, in response to new US duties on steel and aluminum.When asked about the stock Wholesale Vacuum Storage Bag market possibly falling if the US imposes duties on such a large amount of goods, Trump said: “If it does, it does.In a pair of tweets, Trump said “China, the European Union and others have been manipulating their currencies
US President Donald Trump Washington: President Donald Trump said he was ready to impose tariffs on all $500 billion of goods the US imports from China, remarks that sent financial markets retreating and threatened to escalate a trade clash with the Asian giant.”Along with pressing Chinese leaders to shrink the deficit, Trump’s administration has accused China of engaging in unfair trade practices by forcing American investors to turn over technologies to Chinese firms.”After criticizing the Fed in an interview, Trump again lambasted the central bank, saying “Tightening now hurts all that we have done.”Around $505 billion of Chinese goods came into the US in 2017, leading to a trade deficit of nearly $376 billion, US government data shows.Slams Federal Reserve’s decision to hike interest rates... In return, China levied taxes on the same value of US products.“We’re down a tremendous amount,” Trump said in an interview about trade imbalances with China on CNBC broadcast on Friday.US stock index futures, already down on trade worries, fell further after the interview. while the US is raising rates while the dollar gets stronger and stronger with each passing day.Meanwhile, Donald Trump on Friday attacked China and the EU for keeping their currencies artificially low to gain a trade advantage, while again blasting the Federal Reserve for raising interest rates.
The US is currently disputing retaliatory tariffs by China, the European Union, Canada, Mexico and Turkey, in response to new US duties on steel and aluminum.When asked about the stock Wholesale Vacuum Storage Bag
market possibly falling if the US imposes duties on such a large amount of goods, Trump said: “If it does, it does.In a pair of tweets, Trump said “China, the European Union and others have been manipulating their currencies2019年10月17日（木）
NCP leader Supriya Sule at an event at Rashtriya
NCP leader Supriya Sule at an event at Rashtriya Mill Mazdoor Sangh, in Parel on Tuesday.. Ms Sule is in Mumbai for three days to campaign for the upcoming Brihanmumbai Municipal Corporation (BMC) elections. In such a situation, the NCP is bound to project someone who could be seen as moderate with a clean image and is appealing to young voters. She will address women’s gatherings arranged by the party in North, North Central and North West Mumbai and inaugurate election offices of NCP candidates across the city.
Ex-deputy chief minister and Ms Sule’s cousin, Ajit Pawar, is facing corruption charges in a multi-crore irrigation scam, while another strongman and ex-minister, Chhagan Bhujubal, is in the Enforcement Directorate’s (ED’s) custody with regard to a disproportionate assets case. “On one hand, your leaders allege corruption in the BMC and you are simultaneously discussing an alliance with the Shiv Sena. The party’s state president, Sunil Tatkare, is also facing an Anti-Corruption Bureau inquiry into corruption charges during his tenure as irrigation minister.Ms Sule slammed the Bharatiya Janata Party (BJP) over its doublespeak about the Shiv Sena. How come this is even possible?” she asked the BJP in a rally at Parel, where she also inaugurated the party’s social media backroom office for the BMC elections.
Sule is in Mumbai for three days to campaign for the upcoming Brihanmumbai Municipal Corporation elections.Due to a negative perception among voters, born out of such cases, the party had to face severe losses in the 2014 assembly elections and has still not recovered well. Mumbai: Supriya Sule, the daughter of Nationalist Congress Party (NCP) chief Sharad Pawar and two-time Member of Parliament in Lok Sabha, is clearly emerging as a prominent face of the party in the state.
The NCP is facing a leadership crisis, with its second rank of China Vacuum Storage Bag Factory leadership being discredited due to various reasons, including corruption charges. Ms Sule seems to have filled this vacuum to position herself as the leader of the party
Ex-deputy chief minister and Ms Sule’s cousin, Ajit Pawar, is facing corruption charges in a multi-crore irrigation scam, while another strongman and ex-minister, Chhagan Bhujubal, is in the Enforcement Directorate’s (ED’s) custody with regard to a disproportionate assets case. “On one hand, your leaders allege corruption in the BMC and you are simultaneously discussing an alliance with the Shiv Sena. The party’s state president, Sunil Tatkare, is also facing an Anti-Corruption Bureau inquiry into corruption charges during his tenure as irrigation minister.Ms Sule slammed the Bharatiya Janata Party (BJP) over its doublespeak about the Shiv Sena. How come this is even possible?” she asked the BJP in a rally at Parel, where she also inaugurated the party’s social media backroom office for the BMC elections.
Sule is in Mumbai for three days to campaign for the upcoming Brihanmumbai Municipal Corporation elections.Due to a negative perception among voters, born out of such cases, the party had to face severe losses in the 2014 assembly elections and has still not recovered well. Mumbai: Supriya Sule, the daughter of Nationalist Congress Party (NCP) chief Sharad Pawar and two-time Member of Parliament in Lok Sabha, is clearly emerging as a prominent face of the party in the state.
The NCP is facing a leadership crisis, with its second rank of China Vacuum Storage Bag Factory
leadership being discredited due to various reasons, including corruption charges. Ms Sule seems to have filled this vacuum to position herself as the leader of the party